"Texas Oncology is an independent private practice with more than 500 physicians and 210 locations across the state. Meeting the oncology needs of Texans for more than 35 years, the practice includes Texas Center for Proton Therapy, Texas Breast Specialists, Texas Oncology Surgical Specialists, and Texas Center for Interventional Surgery. As a lead participant in US Oncology Research, Texas Oncology played a role in the development of more than 100 FDA-approved therapies."

During the past decade, Texas Oncology - Wichita Falls Texoma Cancer Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 18 clinical trials were completed, i.e. on average, 163.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 10 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Texas Oncology - Wichita Falls Texoma Cancer Center" #1 sponsor was "Radiation Therapy Oncology Group" with 6 trials, followed by "Celgene" with 5 trials sponsored, "US Oncology Research" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "National Cancer Institute (NCI)" with 3 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Oncology - Wichita Falls Texoma Cancer Center" #1 collaborator was "NRG Oncology" with 8 trials as a collaborator, "National Cancer Institute (NCI)" with 8 trials as a collaborator, "ARMO BioSciences" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator and "Sanofi" with 2 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Texas Oncology - Wichita Falls Texoma Cancer Center" are "Breast Cancer" (5 trials), "Non-Small Cell Lung Cancer" (3 trials), "Metastatic Breast Cancer" (2 trials), "Multiple Myeloma" (2 trials) and "Prostate Cancer" (2 trials). Many other conditions were trialed in "Texas Oncology - Wichita Falls Texoma Cancer Center" in a lesser frequency.

Most popular intervention types in "Texas Oncology - Wichita Falls Texoma Cancer Center" are "Drug" (27 trials), "Radiation" (9 trials), "Other" (6 trials), "Biological" (5 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (5 trials), "Paclitaxel" (5 trials), "Cyclophosphamide" (4 trials), "Laboratory Biomarker Analysis" (4 trials) and "Docetaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Texas Oncology - Wichita Falls Texoma Cancer Center" are 24 trials for "All" genders, 8 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Texas Oncology - Wichita Falls Texoma Cancer Center". undefined are not yet recruiting, 3 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Texas Oncology - Wichita Falls Texoma Cancer Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Texas Oncology - Wichita Falls Texoma Cancer Center, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".